Form 4: Clorox Director Boosts Stake with DSU Acquisitions

Clorox Company Director Esther Lee increased her beneficial ownership through multiple acquisitions of Deferred Stock Units, including dividend reinvestments and an annual award.

Summary

• Esther Lee, a Director of The Clorox Company (CLX), reported several acquisitions of Deferred Stock Units (DSUs) throughout 2025.
• The acquisitions totaled 2,178.3857 DSUs, increasing her beneficial ownership.
• These DSUs were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan and an annual award under the 2005 Stock Incentive Plan.
• As of December 31, 2025, Lee beneficially owns a total of 15,677.4328 DSUs.
• Each DSU is convertible on a 1-for-1 basis into Clorox common stock and will be settled upon Lee's retirement or other termination of service as a Director.

Sentiment

Score: 7

Explanation: The filing indicates a director's increased beneficial ownership through routine compensation and dividend reinvestment, which is generally a positive signal of alignment and confidence, though not a direct investment decision.

Positives

• Increased beneficial ownership by a Director, indicating alignment of interests with shareholders.
• Acquisition of DSUs through dividend reinvestment demonstrates a long-term commitment and confidence in the company's performance.
• The annual award of DSUs is a standard component of director compensation, aligning incentives with company performance.

Industry Context

This filing reflects routine insider transaction disclosures common across publicly traded companies, where directors receive compensation in equity and reinvest dividends, aligning their interests with long-term shareholder value. It does not provide specific insights into broader industry trends for consumer goods.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with long-term shareholder value due to increased equity ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The Deferred Stock Units will be settled in Clorox common stock upon the reporting person's retirement or other termination of service as a Director.

Key Dates

Recommendation

This Form 4 filing details routine acquisitions of Deferred Stock Units by a director as part of compensation and dividend reinvestment plans. While it signals continued alignment of management interests with shareholders, it does not represent a new investment decision by the director or provide new fundamental information about the company's performance or outlook that would warrant a change in an existing investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Clorox, CLX, Esther Lee, Director, SEC Form 4, Beneficial Ownership, Deferred Stock Units, DSU, Insider Transaction, Dividend Reinvestment, Stock Incentive Plan, Corporate Governance